1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hemoglobinopathies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Blood Transfusion 1.2.3 Iron Chelation Therapy 1.2.4 Bone Marrow Transplant 1.2.5 Others 1.3 Market by Application 1.3.1 Global Hemoglobinopathies Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Blood Testing 1.3.3 Genetic Testing 1.3.4 Pre-Implantation Genetic Diagnosis (PGD) 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hemoglobinopathies Market Perspective (2016-2027) 2.2 Hemoglobinopathies Growth Trends by Regions 2.2.1 Hemoglobinopathies Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Hemoglobinopathies Historic Market Share by Regions (2016-2021) 2.2.3 Hemoglobinopathies Forecasted Market Size by Regions (2022-2027) 2.3 Hemoglobinopathies Industry Dynamic 2.3.1 Hemoglobinopathies Market Trends 2.3.2 Hemoglobinopathies Market Drivers 2.3.3 Hemoglobinopathies Market Challenges 2.3.4 Hemoglobinopathies Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hemoglobinopathies Players by Revenue 3.1.1 Global Top Hemoglobinopathies Players by Revenue (2016-2021) 3.1.2 Global Hemoglobinopathies Revenue Market Share by Players (2016-2021) 3.2 Global Hemoglobinopathies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hemoglobinopathies Revenue 3.4 Global Hemoglobinopathies Market Concentration Ratio 3.4.1 Global Hemoglobinopathies Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathies Revenue in 2020 3.5 Hemoglobinopathies Key Players Head office and Area Served 3.6 Key Players Hemoglobinopathies Product Solution and Service 3.7 Date of Enter into Hemoglobinopathies Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hemoglobinopathies Breakdown Data by Type 4.1 Global Hemoglobinopathies Historic Market Size by Type (2016-2021) 4.2 Global Hemoglobinopathies Forecasted Market Size by Type (2022-2027) 5 Hemoglobinopathies Breakdown Data by Application 5.1 Global Hemoglobinopathies Historic Market Size by Application (2016-2021) 5.2 Global Hemoglobinopathies Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Hemoglobinopathies Market Size (2016-2027) 6.2 North America Hemoglobinopathies Market Size by Type 6.2.1 North America Hemoglobinopathies Market Size by Type (2016-2021) 6.2.2 North America Hemoglobinopathies Market Size by Type (2022-2027) 6.2.3 North America Hemoglobinopathies Market Size by Type (2016-2027) 6.3 North America Hemoglobinopathies Market Size by Application 6.3.1 North America Hemoglobinopathies Market Size by Application (2016-2021) 6.3.2 North America Hemoglobinopathies Market Size by Application (2022-2027) 6.3.3 North America Hemoglobinopathies Market Size by Application (2016-2027) 6.4 North America Hemoglobinopathies Market Size by Country 6.4.1 North America Hemoglobinopathies Market Size by Country (2016-2021) 6.4.2 North America Hemoglobinopathies Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Hemoglobinopathies Market Size (2016-2027) 7.2 Europe Hemoglobinopathies Market Size by Type 7.2.1 Europe Hemoglobinopathies Market Size by Type (2016-2021) 7.2.2 Europe Hemoglobinopathies Market Size by Type (2022-2027) 7.2.3 Europe Hemoglobinopathies Market Size by Type (2016-2027) 7.3 Europe Hemoglobinopathies Market Size by Application 7.3.1 Europe Hemoglobinopathies Market Size by Application (2016-2021) 7.3.2 Europe Hemoglobinopathies Market Size by Application (2022-2027) 7.3.3 Europe Hemoglobinopathies Market Size by Application (2016-2027) 7.4 Europe Hemoglobinopathies Market Size by Country 7.4.1 Europe Hemoglobinopathies Market Size by Country (2016-2021) 7.4.2 Europe Hemoglobinopathies Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Hemoglobinopathies Market Size (2016-2027) 8.2 Asia-Pacific Hemoglobinopathies Market Size by Type 8.2.1 Asia-Pacific Hemoglobinopathies Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Hemoglobinopathies Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Hemoglobinopathies Market Size by Type (2016-2027) 8.3 Asia-Pacific Hemoglobinopathies Market Size by Application 8.3.1 Asia-Pacific Hemoglobinopathies Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Hemoglobinopathies Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Hemoglobinopathies Market Size by Application (2016-2027) 8.4 Asia-Pacific Hemoglobinopathies Market Size by Region 8.4.1 Asia-Pacific Hemoglobinopathies Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Hemoglobinopathies Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hemoglobinopathies Market Size (2016-2027) 9.2 Latin America Hemoglobinopathies Market Size by Type 9.2.1 Latin America Hemoglobinopathies Market Size by Type (2016-2021) 9.2.2 Latin America Hemoglobinopathies Market Size by Type (2022-2027) 9.2.3 Latin America Hemoglobinopathies Market Size by Type (2016-2027) 9.3 Latin America Hemoglobinopathies Market Size by Application 9.3.1 Latin America Hemoglobinopathies Market Size by Application (2016-2021) 9.3.2 Latin America Hemoglobinopathies Market Size by Application (2022-2027) 9.3.3 Latin America Hemoglobinopathies Market Size by Application (2016-2027) 9.4 Latin America Hemoglobinopathies Market Size by Country 9.4.1 Latin America Hemoglobinopathies Market Size by Country (2016-2021) 9.4.2 Latin America Hemoglobinopathies Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hemoglobinopathies Market Size (2016-2027) 10.2 Middle East & Africa Hemoglobinopathies Market Size by Type 10.2.1 Middle East & Africa Hemoglobinopathies Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Hemoglobinopathies Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Hemoglobinopathies Market Size by Type (2016-2027) 10.3 Middle East & Africa Hemoglobinopathies Market Size by Application 10.3.1 Middle East & Africa Hemoglobinopathies Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Hemoglobinopathies Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Hemoglobinopathies Market Size by Application (2016-2027) 10.4 Middle East & Africa Hemoglobinopathies Market Size by Country 10.4.1 Middle East & Africa Hemoglobinopathies Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Hemoglobinopathies Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Gamida Cell 11.1.1 Gamida Cell Company Details 11.1.2 Gamida Cell Business Overview 11.1.3 Gamida Cell Hemoglobinopathies Introduction 11.1.4 Gamida Cell Revenue in Hemoglobinopathies Business (2016-2021) 11.1.5 Gamida Cell Recent Development 11.2 Alnylam Pharmaceuticals 11.2.1 Alnylam Pharmaceuticals Company Details 11.2.2 Alnylam Pharmaceuticals Business Overview 11.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Introduction 11.2.4 Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2016-2021) 11.2.5 Alnylam Pharmaceuticals Recent Development 11.3 Sanofi 11.3.1 Sanofi Company Details 11.3.2 Sanofi Business Overview 11.3.3 Sanofi Hemoglobinopathies Introduction 11.3.4 Sanofi Revenue in Hemoglobinopathies Business (2016-2021) 11.3.5 Sanofi Recent Development 11.4 Sangamo Therapeutics Inc. 11.4.1 Sangamo Therapeutics Inc. Company Details 11.4.2 Sangamo Therapeutics Inc. Business Overview 11.4.3 Sangamo Therapeutics Inc. Hemoglobinopathies Introduction 11.4.4 Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2016-2021) 11.4.5 Sangamo Therapeutics Inc. Recent Development 11.5 Global Blood Therapeutics 11.5.1 Global Blood Therapeutics Company Details 11.5.2 Global Blood Therapeutics Business Overview 11.5.3 Global Blood Therapeutics Hemoglobinopathies Introduction 11.5.4 Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2016-2021) 11.5.5 Global Blood Therapeutics Recent Development 11.6 Bluebird Bio 11.6.1 Bluebird Bio Company Details 11.6.2 Bluebird Bio Business Overview 11.6.3 Bluebird Bio Hemoglobinopathies Introduction 11.6.4 Bluebird Bio Revenue in Hemoglobinopathies Business (2016-2021) 11.6.5 Bluebird Bio Recent Development 11.7 Emmaus Life Sciences Inc. 11.7.1 Emmaus Life Sciences Inc. Company Details 11.7.2 Emmaus Life Sciences Inc. Business Overview 11.7.3 Emmaus Life Sciences Inc. Hemoglobinopathies Introduction 11.7.4 Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2016-2021) 11.7.5 Emmaus Life Sciences Inc. Recent Development 11.8 Prolong Pharmaceuticals 11.8.1 Prolong Pharmaceuticals Company Details 11.8.2 Prolong Pharmaceuticals Business Overview 11.8.3 Prolong Pharmaceuticals Hemoglobinopathies Introduction 11.8.4 Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2016-2021) 11.8.5 Prolong Pharmaceuticals Recent Development 11.9 Celgene Corporation 11.9.1 Celgene Corporation Company Details 11.9.2 Celgene Corporation Business Overview 11.9.3 Celgene Corporation Hemoglobinopathies Introduction 11.9.4 Celgene Corporation Revenue in Hemoglobinopathies Business (2016-2021) 11.9.5 Celgene Corporation Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hemoglobinopathies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Blood Transfusion Table 3. Key Players of Iron Chelation Therapy Table 4. Key Players of Bone Marrow Transplant Table 5. Key Players of Others Table 6. Global Hemoglobinopathies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Hemoglobinopathies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Hemoglobinopathies Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Hemoglobinopathies Market Share by Regions (2016-2021) Table 10. Global Hemoglobinopathies Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Hemoglobinopathies Market Share by Regions (2022-2027) Table 12. Hemoglobinopathies Market Trends Table 13. Hemoglobinopathies Market Drivers Table 14. Hemoglobinopathies Market Challenges Table 15. Hemoglobinopathies Market Restraints Table 16. Global Hemoglobinopathies Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Hemoglobinopathies Market Share by Players (2016-2021) Table 18. Global Top Hemoglobinopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathies as of 2020) Table 19. Ranking of Global Top Hemoglobinopathies Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Hemoglobinopathies Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Hemoglobinopathies Product Solution and Service Table 23. Date of Enter into Hemoglobinopathies Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Hemoglobinopathies Market Size by Type (2016-2021) (US$ Million) Table 26. Global Hemoglobinopathies Revenue Market Share by Type (2016-2021) Table 27. Global Hemoglobinopathies Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Hemoglobinopathies Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Hemoglobinopathies Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Hemoglobinopathies Revenue Market Share by Application (2016-2021) Table 31. Global Hemoglobinopathies Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Hemoglobinopathies Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Hemoglobinopathies Market Size by Type (2016-2021) (US$ Million) Table 34. North America Hemoglobinopathies Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Hemoglobinopathies Market Size by Application (2016-2021) (US$ Million) Table 36. North America Hemoglobinopathies Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Hemoglobinopathies Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Hemoglobinopathies Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Hemoglobinopathies Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Hemoglobinopathies Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Hemoglobinopathies Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Hemoglobinopathies Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Hemoglobinopathies Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Hemoglobinopathies Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Hemoglobinopathies Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Hemoglobinopathies Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Hemoglobinopathies Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Hemoglobinopathies Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Hemoglobinopathies Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Hemoglobinopathies Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Hemoglobinopathies Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Hemoglobinopathies Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Hemoglobinopathies Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Hemoglobinopathies Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Hemoglobinopathies Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Hemoglobinopathies Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Hemoglobinopathies Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Hemoglobinopathies Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Hemoglobinopathies Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Hemoglobinopathies Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Hemoglobinopathies Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Hemoglobinopathies Market Size by Country (2022-2027) & (US$ Million) Table 63. Gamida Cell Company Details Table 64. Gamida Cell Business Overview Table 65. Gamida Cell Hemoglobinopathies Product Table 66. Gamida Cell Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million) Table 67. Gamida Cell Recent Development Table 68. Alnylam Pharmaceuticals Company Details Table 69. Alnylam Pharmaceuticals Business Overview Table 70. Alnylam Pharmaceuticals Hemoglobinopathies Product Table 71. Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million) Table 72. Alnylam Pharmaceuticals Recent Development Table 73. Sanofi Company Details Table 74. Sanofi Business Overview Table 75. Sanofi Hemoglobinopathies Product Table 76. Sanofi Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million) Table 77. Sanofi Recent Development Table 78. Sangamo Therapeutics Inc. Company Details Table 79. Sangamo Therapeutics Inc. Business Overview Table 80. Sangamo Therapeutics Inc. Hemoglobinopathies Product Table 81. Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million) Table 82. Sangamo Therapeutics Inc. Recent Development Table 83. Global Blood Therapeutics Company Details Table 84. Global Blood Therapeutics Business Overview Table 85. Global Blood Therapeutics Hemoglobinopathies Product Table 86. Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million) Table 87. Global Blood Therapeutics Recent Development Table 88. Bluebird Bio Company Details Table 89. Bluebird Bio Business Overview Table 90. Bluebird Bio Hemoglobinopathies Product Table 91. Bluebird Bio Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million) Table 92. Bluebird Bio Recent Development Table 93. Emmaus Life Sciences Inc. Company Details Table 94. Emmaus Life Sciences Inc. Business Overview Table 95. Emmaus Life Sciences Inc. Hemoglobinopathies Product Table 96. Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million) Table 97. Emmaus Life Sciences Inc. Recent Development Table 98. Prolong Pharmaceuticals Company Details Table 99. Prolong Pharmaceuticals Business Overview Table 100. Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million) Table 101. Prolong Pharmaceuticals Recent Development Table 102. Celgene Corporation Company Details Table 103. Celgene Corporation Business Overview Table 104. Celgene Corporation Hemoglobinopathies Product Table 105. Celgene Corporation Revenue in Hemoglobinopathies Business (2016-2021) & (US$ Million) Table 106. Celgene Corporation Recent Development Table 107. Research Programs/Design for This Report Table 108. Key Data Information from Secondary Sources Table 109. Key Data Information from Primary Sources List of Figures Figure 1. Global Hemoglobinopathies Market Share by Type: 2020 VS 2027 Figure 2. Blood Transfusion Features Figure 3. Iron Chelation Therapy Features Figure 4. Bone Marrow Transplant Features Figure 5. Others Features Figure 6. Global Hemoglobinopathies Market Share by Application: 2020 VS 2027 Figure 7. Blood Testing Case Studies Figure 8. Genetic Testing Case Studies Figure 9. Pre-Implantation Genetic Diagnosis (PGD) Case Studies Figure 10. Others Case Studies Figure 11. Hemoglobinopathies Report Years Considered Figure 12. Global Hemoglobinopathies Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Hemoglobinopathies Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Hemoglobinopathies Market Share by Regions: 2020 VS 2027 Figure 15. Global Hemoglobinopathies Market Share by Regions (2022-2027) Figure 16. Global Hemoglobinopathies Market Share by Players in 2020 Figure 17. Global Top Hemoglobinopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathies as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Hemoglobinopathies Revenue in 2020 Figure 19. Global Hemoglobinopathies Revenue Market Share by Type (2016-2021) Figure 20. Global Hemoglobinopathies Revenue Market Share by Type (2022-2027) Figure 21. North America Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Hemoglobinopathies Market Share by Type (2016-2027) Figure 23. North America Hemoglobinopathies Market Share by Application (2016-2027) Figure 24. North America Hemoglobinopathies Market Share by Country (2016-2027) Figure 25. United States Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Hemoglobinopathies Market Share by Type (2016-2027) Figure 29. Europe Hemoglobinopathies Market Share by Application (2016-2027) Figure 30. Europe Hemoglobinopathies Market Share by Country (2016-2027) Figure 31. Germany Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Hemoglobinopathies Market Share by Type (2016-2027) Figure 39. Asia-Pacific Hemoglobinopathies Market Share by Application (2016-2027) Figure 40. Asia-Pacific Hemoglobinopathies Market Share by Region (2016-2027) Figure 41. China Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Hemoglobinopathies Market Share by Type (2016-2027) Figure 49. Latin America Hemoglobinopathies Market Share by Application (2016-2027) Figure 50. Latin America Hemoglobinopathies Market Share by Country (2016-2027) Figure 51. Mexico Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Hemoglobinopathies Market Share by Type (2016-2027) Figure 55. Middle East & Africa Hemoglobinopathies Market Share by Application (2016-2027) Figure 56. Middle East & Africa Hemoglobinopathies Market Share by Country (2016-2027) Figure 57. Turkey Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Hemoglobinopathies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Gamida Cell Revenue Growth Rate in Hemoglobinopathies Business (2016-2021) Figure 61. Alnylam Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2016-2021) Figure 62. Sanofi Revenue Growth Rate in Hemoglobinopathies Business (2016-2021) Figure 63. Sangamo Therapeutics Inc. Revenue Growth Rate in Hemoglobinopathies Business (2016-2021) Figure 64. Global Blood Therapeutics Revenue Growth Rate in Hemoglobinopathies Business (2016-2021) Figure 65. Bluebird Bio Revenue Growth Rate in Hemoglobinopathies Business (2016-2021) Figure 66. Emmaus Life Sciences Inc. Revenue Growth Rate in Hemoglobinopathies Business (2016-2021) Figure 67. Prolong Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2016-2021) Figure 68. Celgene Corporation Revenue Growth Rate in Hemoglobinopathies Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed